Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Immune Cell Therapy Market Size (2018-2033)
2.2 Immune Cell Therapy Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global Immune Cell Therapy Market Size by Region (2018-2023)
2.4 Global Immune Cell Therapy Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 Immune Cell Therapy Countries Ranking by Market Size
3 Immune Cell Therapy Competitive by Company
3.1 Global Immune Cell Therapy Revenue by Players
3.1.1 Global Immune Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Immune Cell Therapy Market Share by Players (2018-2023)
3.2 Global Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Immune Cell Therapy Revenue
3.4 Global Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Revenue in 2023
3.5 Global Key Players of Immune Cell Therapy Head office and Area Served
3.6 Global Key Players of Immune Cell Therapy, Product and Application
3.7 Global Key Players of Immune Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Immune Cell Therapy Breakdown Data by Type
4.1 Global Immune Cell Therapy Historic Revenue by Type (2018-2023)
4.2 Global Immune Cell Therapy Forecasted Revenue by Type (2024-2033)
5 Global Immune Cell Therapy Breakdown Data by Application
5.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immune Cell Therapy Revenue by Company (2021-2023)
6.2 North America Immune Cell Therapy Revenue by Type (2018-2033)
6.3 North America Immune Cell Therapy Revenue by Application (2018-2033)
6.4 North America Immune Cell Therapy Revenue by Country (2018-2033)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Immune Cell Therapy Revenue by Company (2021-2023)
7.2 Europe Immune Cell Therapy Revenue by Type (2018-2033)
7.3 Europe Immune Cell Therapy Revenue by Application (2018-2033)
7.4 Europe Immune Cell Therapy Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Immune Cell Therapy Revenue by Company (2021-2023)
8.2 Asia Pacific Immune Cell Therapy Revenue by Type (2018-2033)
8.3 Asia Pacific Immune Cell Therapy Revenue by Application (2018-2033)
8.4 Asia Pacific Immune Cell Therapy Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Immune Cell Therapy Revenue by Company (2021-2023)
9.2 Latin America Immune Cell Therapy Revenue by Type (2018-2033)
9.3 Latin America Immune Cell Therapy Revenue by Application (2018-2033)
9.4 Latin America Immune Cell Therapy Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immune Cell Therapy Revenue by Company (2021-2023)
10.2 Middle East and Africa Immune Cell Therapy Revenue by Type (2018-2033)
10.3 Middle East and Africa Immune Cell Therapy Revenue by Application (2018-2033)
10.4 Middle East and Africa Immune Cell Therapy Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Immune Cell Therapy Products and Services
11.1.4 Adaptimmune Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.1.5 Adaptimmune Immune Cell Therapy SWOT Analysis
11.1.6 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation Immune Cell Therapy Products and Services
11.2.4 Altor Bioscience Corporation Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Immune Cell Therapy SWOT Analysis
11.2.6 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis Immune Cell Therapy Products and Services
11.3.4 Cellectis Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.3.5 Cellectis Immune Cell Therapy SWOT Analysis
11.3.6 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Immune Cell Therapy Products and Services
11.4.4 Juno Therapeutics Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.4.5 Juno Therapeutics Immune Cell Therapy SWOT Analysis
11.4.6 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma Immune Cell Therapy Products and Services
11.5.4 Kite Pharma Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.5.5 Kite Pharma Immune Cell Therapy SWOT Analysis
11.5.6 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Immune Cell Therapy Products and Services
11.6.4 Novartis Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.6.5 Novartis Immune Cell Therapy SWOT Analysis
11.6.6 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Immune Cell Therapy Products and Services
11.7.4 Takara Bio Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.7.5 Takara Bio Immune Cell Therapy SWOT Analysis
11.7.6 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics Immune Cell Therapy Products and Services
11.8.4 Unum Therapeutics Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023)
11.8.5 Unum Therapeutics Immune Cell Therapy SWOT Analysis
11.8.6 Unum Therapeutics Recent Development
12 Immune Cell Therapy Market Dynamics
12.1 Immune Cell Therapy Industry Trends
12.2 Immune Cell Therapy Market Drivers
12.3 Immune Cell Therapy Market Challenges
12.4 Immune Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Immune Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global Immune Cell Therapy Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 7. Global Immune Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Immune Cell Therapy Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 9. Global Immune Cell Therapy Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 10. Global Immune Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global Immune Cell Therapy Market Share by Players (2018-2023)
Table 12. Global Top Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Table 13. Ranking of Global Top Immune Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 14. Global 5 Largest Players Market Share by Immune Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of Immune Cell Therapy, Headquarters and Area Served
Table 16. Global Key Players of Immune Cell Therapy, Product and Application
Table 17. Global Key Players of Immune Cell Therapy, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global Immune Cell Therapy Revenue Market Share by Type (2018-2023)
Table 21. Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 22. Global Immune Cell Therapy Revenue Market Share by Type (2024-2033)
Table 23. Global Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global Immune Cell Therapy Revenue Market Share by Application (2018-2023)
Table 25. Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 26. Global Immune Cell Therapy Revenue Market Share by Application (2024-2033)
Table 27. North America Immune Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 30. North America Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. North America Immune Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Immune Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America Immune Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 35. Europe Immune Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 38. Europe Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 40. Europe Immune Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Europe Immune Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe Immune Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 43. Asia Pacific Immune Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 46. Asia Pacific Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 48. Asia-Pacific Immune Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 49. Asia Pacific Immune Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific Immune Cell Therapy Revenue by Region (2024-2033) & (US$ Million)
Table 51. Latin America Immune Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 54. Latin America Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 56. Latin America Immune Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 57. Latin America Immune Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America Immune Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 59. Middle East and Africa Immune Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 62. Middle East and Africa Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 64. Middle East and Africa Immune Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East and Africa Immune Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Immune Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 67. Adaptimmune Company Details
Table 68. Adaptimmune Business Overview
Table 69. Adaptimmune Immune Cell Therapy Product and Services
Table 70. Adaptimmune Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. Adaptimmune Immune Cell Therapy SWOT Analysis
Table 72. Adaptimmune Recent Development
Table 73. Altor Bioscience Corporation Company Details
Table 74. Altor Bioscience Corporation Business Overview
Table 75. Altor Bioscience Corporation Immune Cell Therapy Product and Services
Table 76. Altor Bioscience Corporation Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 77. Altor Bioscience Corporation Immune Cell Therapy SWOT Analysis
Table 78. Altor Bioscience Corporation Recent Development
Table 79. Cellectis Company Details
Table 80. Cellectis Business Overview
Table 81. Cellectis Immune Cell Therapy Product and Services
Table 82. Cellectis Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 83. Cellectis Immune Cell Therapy SWOT Analysis
Table 84. Cellectis Recent Development
Table 85. Juno Therapeutics Company Details
Table 86. Juno Therapeutics Business Overview
Table 87. Juno Therapeutics Immune Cell Therapy Product and Services
Table 88. Juno Therapeutics Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 89. Juno Therapeutics Immune Cell Therapy SWOT Analysis
Table 90. Juno Therapeutics Recent Development
Table 91. Kite Pharma Company Details
Table 92. Kite Pharma Business Overview
Table 93. Kite Pharma Immune Cell Therapy Product and Services
Table 94. Kite Pharma Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. Kite Pharma Immune Cell Therapy SWOT Analysis
Table 96. Kite Pharma Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Immune Cell Therapy Product and Services
Table 100. Novartis Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 101. Novartis Immune Cell Therapy SWOT Analysis
Table 102. Novartis Recent Development
Table 103. Takara Bio Company Details
Table 104. Takara Bio Business Overview
Table 105. Takara Bio Immune Cell Therapy Product and Services
Table 106. Takara Bio Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 107. Takara Bio Immune Cell Therapy SWOT Analysis
Table 108. Takara Bio Recent Development
Table 109. Unum Therapeutics Company Details
Table 110. Unum Therapeutics Business Overview
Table 111. Unum Therapeutics Immune Cell Therapy Product and Services
Table 112. Unum Therapeutics Immune Cell Therapy Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 113. Unum Therapeutics Immune Cell Therapy SWOT Analysis
Table 114. Unum Therapeutics Recent Development
Table 115. Immune Cell Therapy Market Trends
Table 116. Immune Cell Therapy Market Drivers
Table 117. Immune Cell Therapy Market Challenges
Table 118. Immune Cell Therapy Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Cell Therapy Product Picture
Figure 2. Global Immune Cell Therapy Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global Immune Cell Therapy Market Share by Type: 2023 VS 2033
Figure 4. T Cell Therapy Features
Figure 5. Natural Killer (NK) Cell Therapy Features
Figure 6. Other Features
Figure 7. Global Immune Cell Therapy Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 8. Global Immune Cell Therapy Market Share by Application: 2023 VS 2033
Figure 9. Stomach Cancer
Figure 10. Lung Cancer
Figure 11. Colorectal Cancer
Figure 12. Esophageal Cancer
Figure 13. Pancreatic Cancer
Figure 14. Other
Figure 15. Immune Cell Therapy Report Years Considered
Figure 16. Global Immune Cell Therapy Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 17. Global Immune Cell Therapy Market Size 2018-2033 (US$ Million)
Figure 18. Global Immune Cell Therapy Market Size Market Share by Region: 2023 VS 2033
Figure 19. Global Immune Cell Therapy Revenue Market Share by Region in 2018 VS 2023
Figure 20. Global Immune Cell Therapy Revenue Market Share Forecast by Region (2024-2033)
Figure 21. Global Top 10 Immune Cell Therapy Countries Ranking by Market Size (US$ Million) in 2023
Figure 22. Global Immune Cell Therapy Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 23. Global Immune Cell Therapy Market Share by Players in 2023
Figure 24. Global Top Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Figure 25. The Top 10 and 5 Players Market Share by Immune Cell Therapy Revenue in 2023
Figure 26. North America Immune Cell Therapy Revenue Market Share by Company in 2023
Figure 27. North America Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 28. North America Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 29. North America Immune Cell Therapy Revenue Share by Country (2018-2033)
Figure 30. U.S. Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 31. Canada Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 32. Europe Immune Cell Therapy Revenue Market Share by Company in 2023
Figure 33. Europe Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 34. Europe Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 35. Europe Immune Cell Therapy Revenue Share by Country (2018-2033)
Figure 36. Germany Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 37. France Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 38. U.K. Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 39. Italy Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 40. Russia Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 41. Asia Pacific Immune Cell Therapy Revenue Market Share by Company in 2023
Figure 42. Asia Pacific Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 43. Asia Pacific Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 44. Asia Pacific Immune Cell Therapy Revenue Share by Region (2018-2033)
Figure 45. China Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 46. Japan Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 47. South Korea Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 48. India Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 49. Australia Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 50. Taiwan Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 51. Indonesia Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 52. Thailand Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 53. Malaysia Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 54. Philippines Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 55. Vietnam Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 56. Latin America Immune Cell Therapy Revenue Market Share by Company in 2023
Figure 57. Latin America Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 58. Latin America Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 59. Latin America Immune Cell Therapy Revenue Share by Country (2018-2033)
Figure 60. Mexico Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 61. Brazil Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 62. Argentina Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 63. Middle East and Africa Immune Cell Therapy Revenue Market Share by Company in 2023
Figure 64. Middle East and Africa Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 65. Middle East and Africa Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 66. Middle East and Africa Immune Cell Therapy Revenue Share by Country (2018-2033)
Figure 67. Turkey Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 68. Saudi Arabia Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 69. U.A.E Immune Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 70. Adaptimmune Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 71. Altor Bioscience Corporation Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 72. Cellectis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 73. Juno Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 74. Kite Pharma Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 75. Novartis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 76. Takara Bio Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 77. Unum Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed